Acadia Pharmaceuticals (ACAD) Amortizatization of Intangibles (2011 - 2026)

Acadia Pharmaceuticals' Amortizatization of Intangibles history runs 16 years deep, the most recent figure standing at $453000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 78.59% year-over-year to $453000.0; the TTM figure through Mar 2026 stood at $3.8 million (down 60.96% YoY), while the FY2025 annual figure was $5.4 million, down 41.7% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $453000.0, down from $670000.0 in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $2.8 million in Q4 2024, with the low at -$447000.0 in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $1.8 million (2023), against an average of $1.5 million.
• The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles soared 1591.0% in 2023, then plunged 78.59% in 2026.
• Acadia Pharmaceuticals' Amortizatization of Intangibles stood at $2.1 million in 2022, then slipped by 15.04% to $1.8 million in 2023, then jumped by 58.35% to $2.8 million in 2024, then slumped by 76.22% to $670000.0 in 2025, then tumbled by 32.39% to $453000.0 in 2026.
• Business Quant data shows ACAD's Amortizatization of Intangibles at $453000.0 in Q1 2026, $670000.0 in Q4 2025, and $1.1 million in Q3 2025.